How Can We Help You
Leverage Technology
to Build Your Business?

SCC and MicroStrategy® Announce CARS®/Analytics

Partnership Provides Pharmaceutical Companies with Decision Support Solutions for More Effective Management of Contracting Strategies and Processes

Portland, ME (March 22, 1999) – Systems Consulting Company, Inc. (SCC), the leading provider of solutions that optimize incentive-driven sales agreement business processes, and MicroStrategy Incorporated (NASDAQ: MSTR), a leading worldwide provider of mission-critical decision support systems, announce the general availability of CARS® /Analytics. Targeted at companies in the Life Sciences industry, CARS/Analytics complements SCC’s highly successful CARS® /IS solution by providing sophisticated analysis and reporting capabilities across the spectrum of mission-critical contract and sales management processes.

With MicroStrategy’s DSS Agent™, DSS Web™, and DSS Server™ at the core of the solution, CARS/Analytics enhances the capabilities and value of SCC’s market-leading CARS/IS solution. CARS/IS is a comprehensive suite of software applications and modules utilized by 70% of the top 25 pharmaceutical companies to implement strategies that more closely align contract performance with market share and profit objectives.

CARS/Analytics enables manufacturers in the Life Sciences industry to determine the profitability of their relationships with various trading partners, such as physicians groups, managed care organizations (MCOs), insurance companies, pharmacy benefit managers (PBMs), wholesalers, and hospital chains. By allowing manufacturers to track key contract performance and sales trends, CARS/Analytics provides the information these companies need to evaluate and redefine sales contract relationships with their trading partners. For example, a drug manufacturer could use CARS/Analytics to determine which MCOs do not meet the sales expectations for a particular product. The manufacturer can then revise these partners’ contracts, providing appropriate incentives to encourage the desired level of sales performance.

CARS/Analytics has several features to provide businesses with a comprehensive resource for contract management, including:

• Web-, intranet- and client/server-based reporting access
• Executive Information System (EIS)
• Flexible ad hoc reporting functionality
• Automated load/synchronization of data
• Packaged analysis and reporting
• Data mart for integration of third-party data sources

"As managed care and other organizations such as state Medicaid agencies, drug store chains and independent retailers grow in size and influence, the need to develop and manage effective contracting strategies becomes a critical success factor for pharmaceutical, biotech, and medical/surgical companies," commented Leigh Powell, vice president of Marketing for SCC. "CARS/Analytics extends the power of SCC’s market-leading CARS/IS product suite to help companies target and achieve strategic objectives such as market share growth, revenue growth and profitability. The failure to effectively manage contracting processes puts products, categories and customer relationships at risk. CARS/Analytics is the only product of its kind to address these critical issues."

"By using CARS/Analytics to analyze various contractual relationships and sales agreements, pharmaceutical companies can streamline operations by leveraging partnerships with their most productive customers and eliminating those that have not met performance expectations," said Sanju K. Bansal, executive vice president and chief operating officer of MicroStrategy Incorporated. "MicroStrategy’s DSS Suite™ provides powerful tools for enabling these companies to analyze the most detailed level of every transaction with their trading partners. By building a solution based on these DSS Suite components, SCC has ensured that its clients have an effective resource for evaluating critical business relationships."

About SCC

SCC is the leading provider of solutions that optimize incentive-driven, sales agreement business processes for the Life Sciences industry. For the fourth year in a row, SCC continues to expand revenues at a rate exceeding 100% while strengthening its dominant position in Life Sciences and moving aggressively to establish a leading presence in the Consumer Goods market. SCC is committed to strong alliances with leading software and consulting organizations such as Siebel Systems, SAP, MicroStrategy and CSC. SCC’s worldwide headquarters is located in Portland, Maine. Their website is www.scc.com. For more information contact Johannah Galgovitch at 207-774-3244.

About MicroStrategy Incorporated

MicroStrategy is a leading worldwide provider of enterprise decision support system (“DSS”) software and related services. MicroStrategy’s product line (“DSS Suite”) enables both active and passive delivery of information from large-scale databases, providing Global 2000 enterprise user communities with timely answers to mission-critical questions.

MicroStrategy’s decision support platform enables users to query and analyze the most detailed, transaction-level databases, turning data into business intelligence. In addition to supporting internal enterprise users, MicroStrategy’s products extend DSS beyond corporate boundaries to customers, partners and supply chain constituencies through a broad range of pull and push technology such as the Internet, e-mail, telephones, pagers and other wireless communications devices. MicroStrategy also offers a comprehensive set of consulting, training and support services for its customers and partners.

For more information, please visit MicroStrategy’s Web site: www.strategy.com.

This press release includes statements that may constitute “forward-looking” statements, usually containing the words believe”, “estimate”, “project”, “expect” or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include continued acceptance of the Company’s products in the marketplace, the timing of significant orders, delays in the Company’s ability to develop or ship new products, market acceptance of new products, competitive factors, general economic conditions, currency fluctuations, and other risks detailed in the Company’s registration statements and periodic reports filed with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

MicroStrategy Intelligence Server, MicroStrategy, MicroStrategy Agent, MicroStrategy Suite, MicroStrategy Web are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.